Table 1B. Samples and variant types utilized in the analytic validation.
| Variants validated | Validation samples | Source of
validation |
Number of variants
for validation |
|---|---|---|---|
| SNVs | 218 clinical samples | Tumor DNA | 2,986 SNV events |
| Indels | 218 clinical samples | Tumor DNA | 674 Indel events |
| Copy number alterations | 198 clinical samples | Tumor DNA | 100 CNA events |
| Gene fusions | 244 clinical samples, 1 cell line,
1 SeraCare reference standard |
Tumor RNA | 121 fusion events |
| MSI | 212 clinical samples | Tumor DNA | 117 loci/sample |
| TMB | 218 clinical samples | Tumor DNA | Exome-wide; Reported
in mutations/Mb |